Welcome to a
New World of Mental Health Care
Over 900 million people worldwide live with a mental health disorder. Zylorion was founded to bring that number down—and change countless lives.
Explore the Global Mental Health CrisisGo
Our global team of industry leaders is unearthing the potential of psychedelic therapy. After years of research and clinical trials, we know that the convergence of technology and psychedelics can help people around the world gain access to life-changing therapy.
Creating New Mental Pathways
Dig into the Zylorion DifferenceGo
Zylorion is a biopharmaceutical company inspired by the natural potential of psychedelics. We are creating a new standard of care—bringing relief and restoring well-being to people experiencing mental health challenges.
We’re creating integrated treatment programs that combine safe and effective drug compounds with technology-enabled therapy programs. Virtual and Augmented reality, artificial intelligence, data mining, and biometrics will work together in tandem with psychedelics and talk therapy to personalize each patient’s experience.
Invest in Us
The behavioural health market is expected to hit $240 billion by 2026. Zylorion is ready to capture a significant piece of that market and advance our aggressive growth plans.
Our research programs target areas of high unmet need. We’re focused on creating long-term shareholder value through a diverse portfolio of intellectual property and regulatory protection.
We can make a meaningful difference in the lives of many—and we’re looking for investment partners to help us achieve it.